Sales and Marketing

Showing 15 posts of 11526 posts found.

Risperdal image

J&J to pay $1 billion for Risperdal charges

January 9, 2012 Sales and Marketing J&J, JJ, Janssen, Risperdal

Johnson & Johnson will pay more than $1 billion in the US to resolve a civil investigation into the marketing …

Celgene appoints Dr David Gillen as its UK and Ireland medical director

January 9, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Celgene

Celgene has appointed former Pfizer man Dr David Gillen as its new UK and Ireland medical director. Gillen brings much …

Merck chief defends ‘bumpy’ 2011

January 6, 2012 Sales and Marketing Kenneth Frazier, Merck

Kenneth Frazier has defended his company’s ‘bumpy’ performance in 2011, and has highlighted key drugs for investors to watch. Frazier …
Merkel and Sarkozy

2011 Year In Review

January 6, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2011, Europe, emerging markets, year in review

A round up of some of the key themes in pharma’s yearEUROPE IN CRISIS While the Eurozone has averted meltdown …

New requirements for the technical validations of Marketing Authorisation Applications

January 6, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The current EU- eCTD v3.1 validation criteria came into force on 1st September 2011 for the technical validation for all …

GSK faces fine over Argentina clinical trial

January 6, 2012 Research and Development, Sales and Marketing Argentina, GSK, Vaccine, deaths, emerging markets

A court in Argentina says GSK should be fined for irregularities in recruitment during a trial in which children died. …
lilly_entrance_web

Lilly pessimistic on 2012 performance

January 6, 2012 Sales and Marketing Eli Lilly, lilly, zyprexa

Lilly is forecasting a drop in revenue and profits for 2012, as it prepares for life without its blockbuster antipsychotic …
Lipitor UK video

Keep prescribing Lipitor – the generics are nearly here, says Pfizer

January 5, 2012 Medical Communications, Sales and Marketing Lipitor, NHS, Pfizer, statin prescribing

Pfizer has launched a campaign to persuade UK doctors to keep prescribing Lipitor ahead of its patent expiry in May. …

Biogen inks $299m deal for rare genetic disorder drug

January 5, 2012 Research and Development, Sales and Marketing Biogen, Isis Pharma

Biogen has signed a new deal with drug discovery firm Isis for its spinal muscular atrophy drug ISIS-SMNRx. Biogen will pay …

UK to expand telehealth to three million people

January 4, 2012 Medical Communications, Sales and Marketing NHS, long term conditions, telecare, telehealth

The NHS is to expand the use of telehealth, allowing doctors to remotely monitor patients with long-term conditions.The government’s Care …

Missing trial data ‘threatens integrity of medicine’

January 4, 2012 Research and Development, Sales and Marketing BMJ, clincial trial data, disclosure

Missing clinical trial data can harm patients and lead to needless costs for health systems, according to new research. A …

NHS leaders say hospital use must be scaled back

January 3, 2012 Sales and Marketing

The NHS Confederation says the government must convince people to let go of the ‘outdated hospital-or-bust’ model of care. Mike …

GSK’s Andrew Witty knighted

January 3, 2012 Sales and Marketing Andrew Witty, GSK

GlaxoSmithKline chief executive Andrew Witty and former ABPI director general Richard Barker were among the recipients in the 2012 New …
p0024

Avastin gains EU licence for ovarian cancer

January 3, 2012 Sales and Marketing Roche, avastin, ovarian

Roche’s Avastin has been granted a new European licence to treat ovarian cancer, which could help offset falling sales of …

NHS on track to make £358 million in drug savings

December 23, 2011 Sales and Marketing DoH, NHS, QIPP

The NHS in England is set to make £358 million in savings from drugs over the financial year, according to …
The Gateway to Local Adoption Series

Latest content